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Abstract
Background: Obesity has long been highlighted for its association with increased incidence of cardiovascular
disease (CVD). Nonetheless, the best adiposity indices to evaluate the CVD risk factors remain contentious and few
studies have been performed in Asian populations. In the present study, we compared the association strength of
percent body fat (PBF) to indirect anthropometric measures of general adiposity (body mass index (BMI) and body
adiposity index (BAI)) and central adiposity (waist circumference (WC), and waist-to-hip ratio (WHR)) for the
prediction of CVD risk factors in healthy men and women living in Singapore.
Methods: A total of 125 individuals (63 men and 62 women) took part in this study. PBF was measured by using
three different techniques, including bioelectrical impedance analysis (BIA), BOD POD, and dual-energy X-ray
absorptiometry (DEXA). Anthropometric measurements (WC, hip circumference (HC), height, and weight), fasting
blood glucose (FBG), fasting serum insulin (FSI), and lipid profiles were determined according to standard protocols.
Correlations of anthropometric measurements and PBF with CVD risk factors were compared.
Results: Irrespective of the measuring techniques, PBF showed strong positive correlations with FSI, HOMA-IR,
TC/HDL, TG/HDL, and LDL/HDL in both genders. While PBF was highly correlated with FBG, SBP, and DBP in
females, no significant relationships were observed in males. Amongst the five anthropometric measures of adiposity,
BAI was the best predictor for CVD risk factors in female participants (r = 0.593 for HOMA-IR, r = 0.542 for TG/HDL, r = 0.
474 for SBP, and r = 0.448 for DBP). For males, the combination of WC (r = 0.629 for HOMA-IR, and r = 0.446 for TG/HDL)
and WHR (r = 0.352 for SBP, and r = 0.366 for DBP) had the best correlation with CVD risk factors.
Conclusion: Measurement of PBF does not outperform the simple anthropometric measurements of obesity, i.e. BAI,
WC, and WHR, in the prediction of CVD risk factors in healthy Asian adults. While measures of central adiposity (WC and
WHR) tend to show stronger associations with CVD risk factors in males, measures of general adiposity (BAI) seems to
be the best predictor in females. The gender differences in the association between adiposity indices and CVD risk
factors may relate to different body fat distribution in males and females living in Singapore. These results may find
further clinical utility to identify patients with CVD risk factors in a more efficient way.
Keywords: Adiposity indices, Central adiposity, Waist circumference, General adiposity, Body adiposity index, Body
composition, Cardiovascular risk factors, Asian
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Background
Obesity (excess adiposity tissue) is a substantial public
health crisis globally with the prevalence increasing rapidly
in Asia [1]. Compared with normal weight people, those
who are overweight or obese are at greater risk for many
diseases, such as cardiovascular disease (CVD), osteoarth-
ritis, diabetes mellitus (DM), and cancers [2, 3]. Despite
the clear evidence linking obesity to various poor health
outcomes, obesity itself is a complex and heterogeneous
condition [4]. Previous study has shown that equally obese
subjects with the same amount of total body fat may have
markedly different risk factor profiles [5]. The accumula-
tion of intra-abdominal (visceral) adiposity was associated
with increased risk of metabolic abnormalities such as in-
sulin resistance and dyslipidemia [5, 6]. However, obese
subjects with a normal metabolic risk profile (known as
metabolically healthy obese individuals) were generally
characterized by low levels of visceral adipose tissue and by
subcutaneous obesity [7]. Therefore, the evaluation of total
body fat alone is insufficient to distinguish between indi-
viduals at high and low risk of CVD. Recent technological
advances have made possible the accurate measurement of
regional fat compartments using magnetic resonance im-
aging (MRI) and computed tomography (CT) [8]. These
methods may be better predictors of obesity-related health
risks, their applications in large epidemiological studies or
clinical practice is, nevertheless, not feasible due to the
complexity and high costs of the instrumentations.
In contrast, simple-to-use anthropometric indices, e.g.
body mass index (BMI; weight in kilograms divided by
square of height in meters), waist circumference (WC),
hip circumference (HC), waist-to-hip ratio (WHR; ratio
of WC to HC), and body adiposity index (BAI; HC divided
by height in meters1.5, and subtracting 18 from the result),
have been widely used as surrogates to correlate with total
and subcutaneous body fat volumes for assessing adiposity-
related risks [9–14]. Despite years of research, the best
measure of adiposity and cut-off values to predict the CVD
risk factors have remained contentious. Previous studies
have reported that BMI was significantly related with vari-
ous health outcomes [9]. It has been suggested that BMI
was equally effective as WC in identifying individuals at in-
creased risk of CVD [10, 11]. Conversely, some studies re-
ported that WC is a better indicator of CVD risk than BMI
and WHR in ethnically diverse groups [12–14], whereas a
high WHR has been identified as an increased risk of dys-
lipidemia, hypertension, CVD and DM compared with BMI
[4]. One explanation of these discrepant results could be at-
tributed to the methodological drawbacks of field methods
used for anthropometry analysis and the differences in par-
ticipant characteristics, e.g. age, gender, ethnicity, diet,
countries where participants reside [15–17]. Compared to
Caucasians, Asians have more visceral adiposity, which is
metabolically more adverse, for the same BMI. To date,
there have been few studies to examine the relationship be-
tween anthropometric adiposity indices to CVD risk factors
in Asian populations. Therefore the first objective of this
study was to correlate measured anthropometric variables
with CVD risk factors, e.g. dyslipidemia, insulin resistance,
and blood pressure, in an adult population in Singapore, a
South-East Asian country. In addition to the simple an-
thropometric measures, the commonly used body fat meas-
uring techniques, i.e. dual-energy X-ray absorptiometry
(DEXA), BOD POD, and bioelectrical impedance analysis
(BIA) were also utilized in this study to estimate the rela-
tionship between percent body fat (PBF) and CVD risk fac-
tors. Therefore, the secondary objective of this study was to
compare the value of simple anthropometric measures of
adiposity to advanced fat measuring techniques for the pre-
diction of CVD risk factors.
Methods
Study design
This study was limited to cross-sectional analyses of data
from participants attending a visit between June 2014 and
June 2015. The participants included 125 healthy adults
aged 21 to 68 years: 63 males (50.4 %) and 62 females
(49.6 %). They were recruited from the general public in
Singapore through advertisements and posters that were
placed around the National University of Singapore cam-
pus, public area and on the Clinical Nutrition Research
Centre (CNRC) website. To be eligible, participants were
required to be Singaporeans or individuals who have re-
sided in Singapore for a minimum of five years, healthy
males and females. Participants were excluded if they were
pregnant or diagnosed with any major diseases. Prior to
the test day, participants were asked to restrict alcohol and
caffeine-containing drinks as well as to refrain themselves
from intense physical activity.
Clinical measures
Participants arrived at the laboratory in the morning after
a 10 h overnight fast. Two finger prick capillary blood
samples were obtained for determining blood glucose con-
centration (FBG, mmol/L) using the HemoCue® 201+ RT
Glucose analyser (HemoCue Ltd, Dronfield, UK). In
addition, a total of 10 mL of venous blood was collected
into Vacutainers (Becton Dickinson Diagnostics). Blood
samples were separated by centrifugation at 1500 rpm for
10 min at 4 °C within 2 h of being drawn and aliquots
were stored at −80 °C until analysis. Fasting serum insulin
(FSI, μU/mL) was measured using the immunochemistry
analyzer COBAS e411 (Roche, HITACHI, USA). Insulin
resistance index HOMA-IR was calculated using FBG and
FSI (HOMA-IR = FBG× FSI/22.5).
Fasting lipid parameters including total cholesterol
(TC), high density lipoprotein (HDL), low density lipo-
protein (LDL), and triglycerides (TG) were measured
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using chemistry analyzer COBAS c311 (Roche, HITA-
CHI, USA). The ratios of TC/HDL, TG/HDL, and LDL/
HDL were calculated from the standard lipid profile.
Systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) were measured with an Omron blood pres-
sure monitor (model HEM-907). The measurements
were done in duplicate and readings were averaged.
Standing height was measured to the nearest millimetre
with a stadiometer. Body weight and composition were
measured to the nearest 0.1 kg by using an 8-electrode BIA
device (Tanita BC-418, Tokyo, Japan). Participants were
weighed in light clothing without footwear. PBF was mea-
sured by using Bod Pod™® Body Composition Tracking Sys-
tem (Cosmed, Rome, Italy; software version 5.2.0) and
DEXA (QDR 4500A, fan-beam densitometer, software ver-
sion 8.21; Hologic, Waltham, USA). WC and HC were
measured with an anthropometric measuring tape while
the participants were dressed in light clothing. Measure-
ments were taken according to the ISAK International
Standards for Anthropometric Assessment guidelines [18].
WC was measured at the minimum circumference be-
tween the iliac crest and the rib cage. HC was measured at
the maximum protuberance of the buttocks. All of these
anthropometric measurements were done in duplicate and
readings were averaged.
The body mass index (BMI) was calculated using weight
(kg) divided by the height squared (m2) whereas the body
adipose index (BAI) was calculated using HC and height
(BAI = (HC in centimetres)/(height in meters)1.5 - 18).
Statistical analysis
Baseline characteristics of the participants were presented
as arithmetic means ± SDs. Baseline characteristics
was compared between the two gender groups by using
independent-samples t tests. Pearson’s correlations were
used to investigate the associations between adiposity in-
dices and various CVD risk factors. Linear regression
models, adjusted for age, were used to examine the ad-
justed associations. All statistical analyses were performed
using Stata 11.1 (StataCorp, College Station, Tex, USA).
Two sided p < 0.05 was considered statistically significant
in all cases.
Results
The clinical characteristics of the study population are
shown in Table 1. Almost equal men (50.4 %) and women
(49.6 %) with similar average age took part in the study.
Amongst the anthropometric measurements, males had
significantly higher height, weight, BMI, WC, and WHR
than females, while females had significantly higher PBF
and BAI than males. With the exception of HDL (1.5 ± 0.3
for males and 1.7 ± 0.4 for females, p = 0.001), systolic
blood pressure (117.7 ± 10.4 for males and 105.3 ± 17.8 for
females, p < 0.001) and diastolic blood pressure (67.7 ± 8.6
for males and 64.4 ± 9.5 for females, p = 0.046), all of the
cardiovascular traits did not differ significantly between
males and females.
Results obtained from Pearson’s correlation were
comparable to those obtained from linear regression
models adjusting for age, e.g. statistically significant re-
sults remained largely unchanged while non-significant
results remained the same (data not shown). Table 2 shows
the associations between various anthropometric adiposity
indices and CVD risk factors in male participants. All five
adiposity indices (i.e. BMI, WC, HC, WHR, and BAI) were
significantly correlated with FSI, HOMA-IR, TG, and TG/
HDL. Comparison of these adiposity indices in the strength
of their correlations with CVD variables revealed that WC
had the best correlation with HOMA-IR (r = 0.629), TC/
HDL (r = 0.315), and TG/HDL (r= 0.446). On the other
hand, WHR was the only adiposity index showing
Table 1 Clinical characteristics of the study population
Total (n = 125) Male (n = 63) Female (n = 62) p value
Age (y) 31.4 ± 12.2 30.6 ± 11.6 32.2 ± 12.8 0.452
Height (cm) 166.5 ± 9.0 172.4 ± 6.8 160.6 ± 6.9 <0.001
Weight (kg) 63.3 ± 13.9 70.3 ± 11.9 56.2 ± 12.2 <0.001
BMI (kg/m2) 22.7 ± 3.9 23.6 ± 3.8 21.7 ± 3.9 0.006
WC (cm) 73.5 ± 10.4 78.0 ± 9.4 68.9 ± 9.4 <0.001
HC (cm) 90.8 ± 7.5 91.7 ± 7.1 89.9 ± 7.8 0.196
WHR 0.81 ± 0.07 0.85 ± 0.06 0.76 ± 0.06 <0.001
PBFa 24.1 ± 8.4 18.8 ± 5.8 29.5 ± 7.2 <0.001
PBFb 25.2 ± 9.4 20.1 ± 7.8 30.4 ± 7.9 <0.001
PBFc 29.2 ± 8.3 23.5 ± 5.6 35.2 ± 6.1 <0.001
BAI 24.4 ± 4.1 22.6 ± 3.5 26.2 ± 3.8 <0.001
SBP (mm Hg) 111.5 ± 15.8 117.7 ± 10.4 105.3 ± 17.8 <0.001
DBP (mm Hg) 66.1 ± 9.2 67.7 ± 8.6 64.4 ± 9.5 0.046
FBG (mmol/L) 4.6 ± 0.5 4.6 ± 0.5 4.5 ± 0.5 0.313
FSI (mU/L) 8.3 ± 5.3 7.9 ± 5.6 8.8 ± 4.9 0.349
HOMA-IR 1.7 ± 1.2 1.6 ± 1.3 1.8 ± 1.2 0.474
TG (mmol/L) 0.86 ± 0.44 0.89 ± 0.40 0.83 ± 0.49 0.472
TC (mmol/L) 5.0 ± 1.4 5.0 ± 1.8 5.1 ± 0.9 0.666
HDL (mmol/L) 1.6 ± 0.4 1.5 ± 0.3 1.7 ± 0.4 0.001
LDL (mmol/L) 3.1 ± 1.2 3.1 ± 1.6 3.0 ± 0.8 0.777
TC/HDL 3.3 ± 1.1 3.5 ± 1.2 3.2 ± 1.0 0.056
TG/HDL 0.62 ± 0.51 0.67 ± 0.45 0.57 ± 0.57 0.277
LDL/HDL 2.1 ± 0.9 2.2 ± 1.0 1.9 ± 0.8 0.051
Values are expressed as mean ± SD. p values indicate results of independent
samples t tests between gender groups
PBF was measured by aBIA, bBOD POD, and cDEXA, respectively
Abbreviations: BAI body adiposity index, BIA bioelectrical impedance analysis,
BMI body mass index, DBP diastolic blood pressure, DEXA dual-energy X-ray
absorptiometry, FBG fasting blood glucose, FSI fasting serum insulin, HC hip
circumference, HDL high density lipoprotein, HOMA-IR homeostasis model
assessment of insulin resistance, LDL low density lipoprotein, SBP systolic
blood pressure, TC total cholesterol, TG triglycerides, WC waist circumference,
WHR waist-to-hip ratio
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significantly association with SBP (r = 0.352) and DBP
(r = 0.366) in males.
The relationships of anthropometric adiposity indices
with CVD risk factors were found to be gender dependent.
As observed in Table 3, BMI, WC, HC, WHR, and BAI
were significantly correlated with all CVD risk factors, ex-
cept for LDL and TC in female participants. Amongst
them, the Pearson’s correlation coefficients of BAI
with HOMA-IR (r = 0.593), TC/HDL (r = 0.522), TG/
HDL (r = 0.542), LDL/HDL (r = 0.497), SBP (r = 0.474),
and DBP (r = 0.448) were the strongest.
As a direct measurement of body adiposity, PBF was
assessed in the strength of its associations with CVD risk
factors as presented in Table 4 (males and females separ-
ately) and Additional file 1: Table S1 (all participants).
Table 4 shows that PBF, measured by three different
techniques, shared a comparable pattern of correlation
for both genders. We found that PBF was significantly
correlated with all CVD risk factors except for TC in fe-
male participants. No significant correlations were ob-
served between PBF and FBG, LDL, TC, SBP, and DBP
in males.
We compared the correlation strength of PBF derived
from BOD POD and anthropometric adiposity indices
with the CVD risk factors in the current study popula-
tion (Fig. 1 for males and Fig. 2 for females). Figure 1
shows that WC outperformed PBF in the strength of its
correlation with HOMA-IR and TG/HDL and WHR had
significant correlations with SBP and DBP, but not PBF
in male participants. Figure 2 shows that BAI had a
comparable correlation with CVD risk factors as PBF in
female participants. The comparison of five anthropo-
metric adiposity indices in their strength of correlations
with CVD risk factors are shown in Additional file 1:
Figures S1 and S2.
Discussion
Although the advanced instrumentations, such as DEXA
and MRI, have been employed to measure PBF accur-
ately, they are not readily available in most epidemio-
logical studies due to the high cost and complexity. In
contrast, anthropometric obesity measurements that re-
flect body fat are of importance in clinical settings be-
cause they require less expense and expertise. Although
several studies have successfully included the anthropo-
metric indices of body adiposity in the assessment of
CVD risk factors [19–22], the best measure to predict
these risk factors remained contentious, especially in
Asians. Previous studies suggested that central obesity
measures were more strongly associated with CVD risk
factors compared with general obesity measures [21]. This
is probably because central obesity is associated with sys-
temic inflammation which directly contributes to CVD
risk [23]. Conversely, some other studies, like ours, re-
ported that the association between general obesity and
CVD was similar to the association between central obes-
ity measures and CVD [24, 25]. We found that both gen-
eral obesity (BMI) and central obesity (WC) correlated
Table 2 Pearson’s correlation coefficients of anthropometric
measurements with cardiovascular risk factors for male
participants (n = 63)
BMI (kg/m2) WC (cm) HC (cm) WHR BAI
FBG (mmol/L) 0.097 0.145 0.108 0.124 0.048
FSI (mU/L) 0.529** 0.628** 0.544** 0.471** 0.403**
HOMA-IR 0.534** 0.629** 0.548** 0.464** 0.408**
TG (mmol/L) 0.411** 0.412** 0.407** 0.264* 0.424**
HDL (mmol/L) −0.267* −0.374** −0.297* −0.330* −0.174
LDL (mmol/L) 0.022 0.049 0.071 0.007 0.048
TC (mmol/L) −0.005 −0.001 0.029 −0.034 0.038
TC/HDL 0.238 0.315* 0.308* 0.210 0.231
TG/HDL 0.428** 0.446** 0.410** 0.322* 0.445**
LDL/HDL 0.209 0.290* 0.292* 0.186 0.200
SBP (mm Hg) 0.138 0.228 0.060 0.352* 0.066
DBP (mm Hg) 0.076 0.200 −0.001 0.366** −0.007
*Correlation is significant at p < 0.05
**Correlation is significant at p < 0.005
Abbreviations: BAI body adiposity index, BMI body mass index, DBP diastolic
blood pressure, FBG fasting blood glucose, FSI fasting serum insulin, HC hip
circumference, HDL high density lipoprotein, HOMA-IR homeostasis model
assessment of insulin resistance, LDL low density lipoprotein, SBP systolic
blood pressure, TC total cholesterol, TG triglycerides, WC waist circumference,
WHR waist-to-hip ratio
Table 3 Pearson’s correlation coefficients of anthropometric
measurements with cardiovascular risk factors for female
participants (n = 62)
BMI (kg/m2) WC (cm) HC (cm) WHR BAI
FBG (mmol/L) 0.444** 0.454** 0.341* 0.420** 0.452**
FSI (mU/L) 0.546** 0.549** 0.466** 0.438** 0.563**
HOMA-IR 0.559** 0.561** 0.465** 0.460** 0.593**
TG (mmol/L) 0.384** 0.417** 0.289* 0.406** 0.541**
HDL (mmol/L) −0.419** −0.398** −0.228 −0.442** −0.509**
LDL (mmol/L) 0.177 0.176 0.214 0.074 0.202
TC (mmol/L) 0.071 0.085 0.161 −0.028 0.075
TC/HDL 0.419** 0.425** 0.304* 0.405** 0.522**
TG/HDL 0.401** 0.422** 0.272* 0.432** 0.542**
LDL/HDL 0.399** 0.402** 0.294* 0.376** 0.497**
SBP (mm Hg) 0.403** 0.385** 0.283* 0.369** 0.474**
DBP (mm Hg) 0.452** 0.433** 0.363** 0.346* 0.448**
*Correlation is significant at p < 0.05
**Correlation is significant at p < 0.005
Abbreviations: BAI body adiposity index, BMI body mass index, DBP diastolic
blood pressure, FBG fasting blood glucose, FSI fasting serum insulin, HC hip
circumference, HDL high density lipoprotein, HOMA-IR homeostasis model
assessment of insulin resistance, LDL low density lipoprotein, SBP systolic
blood pressure, TC total cholesterol, TG triglycerides, WC waist circumference,
WHR waist-to-hip ratio
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significantly more with seven of the CVD risk factors
(FBG, FSI, HOMA-IR, TG, TC/HDL, TG/HDL, LDL/
HDL) than HC when all participants were considered to-
gether. Moreover, WHR correlated the best with HDL,
SBP, and DBP (Additional file 1: Table S1).
BAI was recently proposed to offer a simple-to-use
tool to estimate body adiposity [26]. The assessment of
BAI’s association with CVD risk factors has been done
in various populations with different ethnicities showing
that BAI was inferior to other anthropometric measures
such as BMI and WC as a predictor of CVD risk factors
[20, 27–30]. This present study shows that BAI and PBF
shared a comparable correlation pattern, suggesting that
BAI, as a measure of overall adiposity, seemed to correl-
ate with PBF better than other anthropometric indices.
However, there was no case in which BAI and PBF out-
performed these indices with regards to their correlation
with several CVD risk factors including HDL, TC/HDL,
LDL/HDL, SBP, and DBP in the gender-pooled analyses.
This is consistent with prior investigation of body com-
position and health risk showing that PBF did not per-
form better than BMI or WC in predicting metabolic
risks [31]. Although BAI is related to PBF, it may not be
a good indicator of CVD risks as observed in the current
population. A circumspect approach may be to use WC
and WHR in routine clinical assessment since they are
Fig. 1 Comparison of the correlation strength of PBF derived from BOD POD and WC or WHR with the CVD risk factors, e.g. HOMA-IR, TG/HDL,
SBP, and DBP, in male participants (n = 63)
Table 4 Pearson’s correlation coefficients of PBF with cardiovascular risk factors for male (n = 63) and female (n = 62) participants
PBFa PBFb PBFc
Male Female Male Female Male Female
FBG (mmol/L) 0.087 0.482** 0.015 0.506** 0.041 0.462**
FSI (mU/L) 0.595** 0.589** 0.547** 0.536** 0.524** 0.542**
HOMA-IR 0.581** 0.601** 0.526** 0.583** 0.504** 0.574**
TG (mmol/L) 0.435** 0.426** 0.327* 0.482** 0.300* 0.442**
HDL (mmol/L) −0.462** −0.435** −0.400** −0.359** −0.356* −0.352*
LDL (mmol/L) 0.118 0.255* 0.257* 0.370** 0.195 0.311*
TC (mmol/L) 0.053 0.151 0.191 0.297* 0.138 0.248
TC/HDL 0.432** 0.488** 0.500** 0.519** 0.437** 0.474**
TG/HDL 0.490** 0.440** 0.401** 0.438** 0.361** 0.401**
LDL/HDL 0.405** 0.466** 0.484** 0.501** 0.423** 0.451**
SBP (mm Hg) 0.130 0.452** 0.085 0.462** 0.081 0.408**
DBP (mm Hg) 0.146 0.491** 0.139 0.517** 0.100 0.471**
*Correlation is significant at p < 0.05
**Correlation is significant at p < 0.005
PBF was measured by aBIA, bBOD POD, and cDEXA, respectively
Abbreviations: BIA bioelectrical impedance analysis, DBP diastolic blood pressure, DEXA dual-energy X-ray absorptiometry, FBG fasting blood glucose, FSI fasting
serum insulin, HDL high density lipoprotein, HOMA-IR homeostasis model assessment of insulin resistance, LDL low density lipoprotein, PBF percent body fat, SBP
systolic blood pressure, TC total cholesterol, TG triglycerides
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easy to measure and less prone to measurement and cal-
culation errors [32].
An intriguing result of this study was the pronounced
gender difference in the correlations of body adiposity
measures with CVD risk factors. For male participants,
central obesity (WC and WHR) was more strongly asso-
ciated with CVD risk factors, whereas BAI appeared to
be a better predictor of CVD risk factors in female par-
ticipants (Tables 2 and 3). This may be attributed to the
different distribution of adipose tissue in males and fe-
males. Compared to men who store more fat in the vis-
ceral depot, women store them in the gluteal-femoral
region [33, 34]. Therefore, women had less visceral fat
despite having a higher total body fat [35]. While some
epidemiological studies have concluded that visceral adi-
pose tissue was a stronger correlate of CVD [36, 37],
others have argued that subcutaneous adipose tissue
may have protective effects [38, 39]. It has thus been hy-
pothesized that the different fat distribution in males
and females may contribute to the different correlation
of anthropometric obesity indices with CVD risk factors.
Conclusions
In conclusion, our study reports that several simple an-
thropometric measurements of obesity, i.e. BAI, WC, and
WHR, outperform the measurement of PBF in the predic-
tion of CVD risk factors in healthy males and females living
in Singapore. Our data suggests that the correlations be-
tween obesity indices and CVD risks are gender-dependent.
While measures of central adiposity show stronger associa-
tions with CVD risk factors in males, measures of general
adiposity show stronger associations in females.
Our study has several limitations that warrant further
investigation. This is a cross sectional study and thus
causal inferences cannot be drawn. Moreover, the sam-
ple size of this study is small. Future studies should be
conducted with larger sample sizes. Additionally, although
HOMA-IR has become a widely used clinical and epi-
demiological tool, it is not a direct measurement of insulin
resistance. Therefore, the use of HOMA-IR to assess insu-
lin resistance may have potential problems and needs fur-
ther validation. Despite these limitations, the results of
our study provide evidence of the linkage between simple
anthropometric measurements and the purported associa-
tions between adiposity and health markers.
Additional file
Additional file 1: Supporting information. Table S1. Correlation coefficients
of anthropometric measurements and PBF with cardiovascular risk factors for
all participants. Figure S1. Correlation coefficients between different
anthropometric measurements and CVD risk factors in female participants.
Figure S2. Correlation coefficients between different anthropometric
measurements and CVD risk factors in male participants. (DOCX 25 kb)
Abbreviations
BAI, body adiposity index; BIA, bioelectrical impedance analysis; BMI, body
mass index; CVD, cardiovascular disease; CT, computed tomography; DBP, diastolic
blood pressure; DEXA, dual-energy X-ray absorptiometry; DM, diabetes mellitus;
FBG, fasting blood glucose; FSI, fasting serum insulin; HC, hip circumference; HDL,
high density lipoprotein; HOMA-IR, homeostasis model assessment of
insulin resistance; LDL, low density lipoprotein; MRI, magnetic resonance
imaging; PBF, percent body fat; SBP, systolic blood pressure; TC, total
cholesterol; TG, triglycerides; WC, waist circumference; WHR, waist-to-hip ratio
Acknowledgements




Availability of data and materials
Data supporting our findings can be sent by corresponding author upon
request.
Authors’ contributions
The authors’ responsibilities were as follows: CJH designed the study; XB, SLT,
CL, RQ, and YTL conducted experiments and collected data; XB and SLT
Fig. 2 Comparison of the correlation strength of PBF derived from BOD POD and BAI with the CVD risk factors, e.g. HOMA-IR, TG/HDL, SBP, and
DBP, in female participants (n = 62)
Bi et al. BMC Obesity  (2016) 3:33 Page 6 of 7
analyzed data and wrote the manuscript; all authors reviewed the
manuscript and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was conducted at the CNRC, Singapore Institute for Clinical
Sciences (SICS), Singapore, according to the guidelines laid down in the
Declaration of Helsinki. All procedures involving human subjects were
approved by the National Healthcare Group Domain Specific Review Board
(NHG DSRB, Reference Number: 2013/00783), Singapore. All participants gave
written informed consent prior to participation.
Received: 13 January 2016 Accepted: 30 June 2016
References
1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY.
Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–8.
2. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with
cardiovascular disease. Nature. 2006;444(7121):875–80.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index
and incidence of cancer: A systematic review and meta-analysis of
prospective observational studies. Lancet. 2008;371(9612):569–78.
4. Despres JP. Body fat distribution and risk of cardiovascular disease: An
update. Circulation. 2012;126(10):1301–13.
5. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C.
Regional distribution of body fat, plasma lipoproteins, and cardiovascular
disease. Arteriosclerosis. 1990;10(4):497–511.
6. Tchernof A, Despres JP. Pathophysiology of human visceral obesity:
An update. Physiol Rev. 2013;93(1):359–404.
7. Messier V, Karelis AD, Prud’homme D, Primeau V, Brochu M, Rabasa-Lhoret
R. Identifying metabolically healthy but obese individuals in sedentary
postmenopausal women. Obesity (Silver Spring). 2010;18(5):911–7.
8. Muller MJ, Bosy-Westphal A, Kutzner D, Heller M. Metabolically active
components of fat-free mass and resting energy expenditure in humans:
Recent lessons from imaging technologies. Obes Rev. 2002;3(2):113–22.
9. Lewis CE, McTigue KM, Burke LE, Poirier P, Eckel RH, Howard BV, Allison DB,
Kumanyika S, Pi-Sunyer FX. Mortality, health outcomes, and body mass
index in the overweight range: A science advisory from the American Heart
Association. Circulation. 2009;119(25):3263–71.
10. Satoh H, Kishi R, Tsutsui H. Body mass index can similarly predict the
presence of multiple cardiovascular risk factors in middle-aged Japanese
subjects as waist circumference. Intern Med. 2010;49(11):977–82.
11. Schneider HJ, Glaesmer H, Klotsche J, Bohler S, Lehnert H, Zeiher AM, Marz
W, Pittrow D, Stalla GK, Wittchen HU, DETECT study group. Accuracy of
anthropometric indicators of obesity to predict cardiovascular risk. J Clin
Endocrinol Metab. 2007;92(2):589–94.
12. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. Race-
ethnicity-specific waist circumference cutoffs for identifying cardiovascular
disease risk factors. Am J Clin Nutr. 2005;81(2):409–15.
13. Huang KC, Lee MS, Lee SD, Chang YH, Lin YC, Tu SH, Pan WH. Obesity in
the elderly and its relationship with cardiovascular risk factors in Taiwan.
Obes Res. 2005;13(1):170–8.
14. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass
index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–84.
15. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and
risk of type 2 diabetes: A prospective study among Japanese Americans.
Diabetes Care. 2000;23(4):465–71.
16. Chan JM, Rimm EB, Colditz CA, Stampfer MJ, Willett WC. Obesity, fat
distribution, and weight gain as risk factors for clinical diabetes in men.
Diabetes Care. 1994;17(9):961–9.
17. Spiegelman D, Israel RG, Bouchard C, Willett WC. Absolute fat mass, percent
body fat, and body-fat distribution: Which is the real determinant of blood
pressure and serum glucose? Am J Clin Nutr. 1992;55(6):1033–44.
18. ISAK, International standards for anthropometric assessment. Published by
The International Society for the Advancement of Kinanthropometry.
19. Lichtash CT, Cui J, Guo X, Chen YDI, Hsueh WA, Rotter JI, Goodarzi
MO. Body adiposity index versus body mass index and other
anthropometric traits as correlates of cardiometabolic risk factors.
PLoS ONE. 2013;8(6):e65954.
20. Elisha B, Rabasa-Lhoret R, Messier V, Abdulnour J, Karelis AD. Relationship
between the body adiposity index and cardiometabolic risk factors in obese
postmenopausal women. Eur J Nutr. 2013;52(1):145–51.
21. Goh LGH, Dhaliwal SS, Welborn TA, Lee AH, Della PR. Anthropometric
measurements of general and central obesity and the prediction of
cardiovascular disease risk in women: a cross-sectional study. BMJ
Open. 2014;4(2):e004138.
22. Lam BCC, Koh GCH, Chen C, Tack M, Wong K, Fallows SJ. Comparison of
body mass index (BMI), body adiposity index (BAI), waist circumference
(WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors
of cardiovascular disease risk factors in an adult population in Singapore.
PLoS ONE. 2015;10(4):e0122985.
23. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular
disease. Circ Res. 2005;96(9):939–49.
24. Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW,
Wannamethee SG, Lawlor DA. Comparison of the associations of body mass
index and measures of central adiposity and fat mass with coronary heart
disease, diabetes, and all-cause mortality: A study using data from 4 UK
cohorts. Am J Clin Nutr. 2010;91(3):547–56.
25. van Dis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM. Body mass
index and waist circumference predict both 10-year nonfatal and fatal
cardiovascular disease risk: Study conducted in 20,000 Dutch men and
women aged 20–65 years. Eur J Cardiovasc Prev Rehabil. 2009;16(6):729–34.
26. Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring
NG, Xiang AH, Watanabe RM. A better index of body adiposity. Obesity
(Silver Spring). 2011;19(5):1083–9.
27. Schulze MB, Thorand B, Fritsche A, Häring HU, Schick F, Zierer A,
Rathmann W, Kröger J, Peters A, Boeing H, Stefan N. Body adiposity
index, body fat content and incidence of type 2 diabetes.
Diabetologia. 2012;55(6):1660–7.
28. de Lima JG, Nobrega LH, de Souza AB. Body adiposity index indicates only
total adiposity, not risk. Obesity (Silver Spring). 2012;20(6):1140.
29. Snijder MB, Nicolaou M, van Valkengoed IG, Brewster LM, Stronks K. Newly
proposed body adiposity index (BAI) by Bergman et al. is not strongly related
to cardiovascular health risk. Obesity (Silver Spring). 2012;20(6):1138–9.
30. Freedman DS, Blanck HM, Dietz WH, DasMahapatra P, Srinivasan SR,
Berenson GS. Is the body adiposity index (hip circumference/height1.5)
more strongly related to skinfold thickness and risk factor levels than is BMI?
The Bogalusa Heart Study. Br J Nutr. 2013;109(2):338–45.
31. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J,
Müller MJ. Value of body fat mass vs anthropometric obesity indices in the
assessment of metabolic risk factors. Int J Obes (Lond). 2006;30(3):475–83.
32. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative
evaluation of waist circumference, waist-to-hip ratio and body mass index
as indicators of cardiovascular risk factors. The Canadian Heart Health
Surveys. Int J Obes Relat Metab Disord. 2001;25(5):652–61.
33. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab
Care. 2001;4(6):499–502.
34. Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human
adipose tissues-the biology of pear shape. Biol Sex Differ. 2012;3:13.
35. Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Despres JP. Sex
differences in the relation of visceral adipose tissue accumulation to total
body fatness. Am J Clin Nutr. 1993;58(4):463–7.
36. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY,
Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr, O’Donnell
CJ.. Abdominal visceral and subcutaneous adipose tissue compartments:
Association with metabolic risk factors in the Framingham Heart Study.
Circulation. 2007;116(1):39–48.
37. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA.
Impact of abdominal visceral and subcutaneous adipose tissue on
cardiometabolic risk factors: The Jackson Heart Study. J Clin Endocrinol
Metab. 2010;95(12):5419–26.
38. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous
fat transplantation on metabolism. Cell Metab. 2008;7(5):410–20.
39. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS.
Abdominal subcutaneous adipose tissue: A protective fat depot? Diabetes
Care. 2009;32(6):1068–75.
Bi et al. BMC Obesity  (2016) 3:33 Page 7 of 7
